期刊文献+

基于单纯型设计和部件搜索方法的CHO细胞无血清培养基的高通量优化 被引量:5

High Through-Put Screening and Optimization of Serum-free Media Development for CHO Cells Using Simplex Lattice and Elements Dialogue Design Methods
下载PDF
导出
摘要 氨基酸的浓度与配比对细胞生长和产物表达有重要作用。在自主研发无血清培养基的基础上,通过单纯型格子实验设计优化氨基酸浓度及配比后发现,优化的无血清培养基明显促进了细胞生长。生物反应器批式培养中,最高活细胞密度达52.6×105 cells·mL-1,抗体融合蛋白产量52.2 mg·L-1,相对于商业培养基Ex-cell 302,分别提高了26.7%和11.5%。在此基础上,通过部件搜索的方法确认具有显著正影响的氨基酸为谷氨酰胺、脯氨酸和甲硫氨酸。基于上述研究工作,在2 L反应器采用自主研发的优化无血清培养基,以葡萄糖为关键控制参数,进行两阶段动态流加培养过程,CHO细胞最大活细胞密度达94.6×105 cells·mL-1,抗体融合蛋白终产量600 mg·L-1,相对于商业培养基Ex-cell 302批式培养,分别提高了2.75倍和11.8倍。本研究工作为抗体融合蛋白的高效工业化生产奠定了基础。 Based on statistical analysis, cell growth was optimization of the concentration and proportion of amino design methods. Using the optimized serum-free media, maximum antibody concentration are 52.6×10^5 cells.mL^ 1 improved in optimized serum-free media via the acids using simplex lattice and elements dialogue the maximum viable cell density (MVCD) and the and 52.2 mg.L^1, respectively, and these values are increased by 26.7% and 11.5% respectively comparing to those obtained by using the commercial medium Ex-cell302. Glutamine, proline and methiorline are confirmed to have positive effects through the elements dialogue experiment. Moreover, two-stage dynamic fed-batch culture for CHO cells was studied in a 2 L bioreactor. The feeding strategy was based on using the glucose concentration as the key controlling parameter. The maximum viable cell density reaches to 94.6×10^5 cells.mL^11, and 600 mg.L^- 1 antibody concentration was achieved within 10 days of cultivation. The maximum cell concentration and antibody production are improved by 2.75 and 11.8 times comparing to the results obtained by commercial medium cultivation. This research is useful for efficient industrial production of antibody fusion proteins.
出处 《高校化学工程学报》 EI CAS CSCD 北大核心 2014年第4期777-783,共7页 Journal of Chemical Engineering of Chinese Universities
基金 国家重点实验室专项经费资助(21106045) 上海高校青年教师培养资助计划(11011)
关键词 CHO细胞 无血清培养基 高通量筛选技术 氨基酸优化 CHO cells serum-free medium high through-put screening amino acids optimization
  • 相关文献

参考文献15

  • 1Wurm F M. Production of recombinant protein therapeutics in cultivated mammalian cells [J]. Nat Biotechnol, 2004, 22(11):1393-1398.
  • 2Butler M. Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals [J]. Appl MicrobiolBiotechnol, 2005, 68(3): 283-291.
  • 3陈志南,杨向民.基于抗体等重组蛋白表达产品的哺乳动物细胞大规模发酵技术[J].中国医药生物技术,2009,4(5):325-328. 被引量:11
  • 4Matasci M, Hacker D L, Baldi L, et al. Recombinant therapeutic protein production in cultivated mammalian cells: current status andfuture prospects [J]. Drug. Discovery Today: Technologies, 2008, 5(2): 37-42.
  • 5Li F, Vijayasankaran N, Shen Y J, et al. Cell culture processes for monoclonal antibody production [J]. Mabs, 2010, 2(5): 466-477.
  • 6Jordan M, Voisard D, Berthoud A, et al. Cell culture medium improvement by rigorous shuffling of components using mediablending [J]. Cytotechnology, 2013, 65(1): 31-40.
  • 7Rouiller Y, Préilleux A, Collet N, et al. A high-throughput media design approach for high performance mammalian fed-batchcultures [J]. MAbs, 2013, 5(3): 501-511.
  • 8González L J, Carrillo C L M, Ramírez M A, et al. Use of a Plackett-Burman statistical design to determine the effect of selectedamino acids on monoclonal antibody production in CHO cells [J]. Biotechnol Prog, 2011, 27(6): 1709-1717.
  • 9Barrett T A, Wu A, Zhang H, et al. Microwell engineering characterization for mammalian cell culture process development [J].Biotechnol Bioeng, 2009, 105(2): 260-275.
  • 10Bareither R, Pollard D. A review of advanced small-scale parallel bioreactor technology for accelerated process development: currentstate and future need [J]. Biotechnol Prog, 2010, 27(1): 2-14.

二级参考文献17

  • 1Tang YJ, Ohashi R, Hamel JF. Perfusion culture of hybridoma cells for hyperproduction of IgG(2a) monoclonal antibody in a wave bioreactor-perfusion culture system. Biotechnol Prog, 2007, 23(1): 255-264.
  • 2Kretzmer G. Industrial processes with animal cells. Appl Biochem Biotechnol, 2002, 59(2/3):135-142.
  • 3Schenerman MA, Hope JN, Kletke C, et al. Comparability testing of a humanized mAb (Synagis) to support cell line stability, process validation, and scale-up for manufacturing. Biologicals, 1999, 27(3):203-215.
  • 4Wiktor TJ, MacFarlan RI, Reagan K J, et al. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Biotechnology. 1992;24:508-12.
  • 5Meuwly F, Weber U, Ziegler T, et al. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality. J Biotechnol, 2006, 123(1): 106-116.
  • 6Ye J, Kober V, Tellers M, et al. High-level protein expression in scalable CHO transient transfection. Biotechnol Bioeng, 2009, 103(3):542-551.
  • 7Galbraith DJ, Tait AS, Racher A J, et al. Control of culture environment for improved polyethylenirnine-mediated transient production of recombinant monoclonal antibodies by CHO cells. Biotechnol Prog, 2006, 22(3):753-762.
  • 8Gaillet B, Gilbert R, Amziani R, et al. High-level recombinant protein production in CHO cells using an adenoviral vector and the cumate gene-switch. Biotechnol Prog. 2007, 23(1):200-209.
  • 9Pattison RN, Swamy J, Mendenhall B, et al. Measurement and control of dissolved carbon dioxide in mammalian cell culture processes using an in situ fiber optic chemical sensor. Biotechnol Prog, 2000, 16:769-774.
  • 10Chirino AJ, Mire-Sluis A. Characterizing biological products and assessing comparability following manufacturing changes. Nat Biotechnol, 2004, 22:1383-1391.

共引文献14

同被引文献48

  • 1张小燕,安美玲,蔡兴顺.多因素单纯形最优化方法快速搜寻最佳检测条件[J].西北大学学报(自然科学版),1993,23(2):109-118. 被引量:6
  • 2赵亮,朱明龙,张旭,谭文松.钙离子对293细胞结团和生长的影响[J].生物工程学报,2005,21(3):482-485. 被引量:4
  • 3杨涛,马传国,李庆鹏,李娜.不同工艺条件对大豆分离蛋白7S和11S组分影响的探讨[J].粮食加工,2007,32(5):91-96. 被引量:9
  • 4姚善泾,高栋,林东强.一种新的生物分离方法——混合模式吸附层析[J].化工学报,2007,58(9):2169-2177. 被引量:17
  • 5埘庆阁.口蹄疫[M].北京:中国农业出版社,2004:175.176.
  • 6Bolwell C, Brown AL, Barnett PV, et al. Host cell selection of ~mtigenic variants of foot-and-mouth disease vinis [ J ] . J GenVirol, 1989, 70 ( Pt 1 ) : 45-57.
  • 7Amadori M, Volpe G, Defilippi P, et al. Phenotypic features of BHK-21 cells used for production of foot-and-mouth disease vaccine [ J ] . Biologieals, 1997, 25 ( 1 ) : 65-73.
  • 8Duygu AT, Ayse N, Murat E, et al. Cultivation and comparison of BHK-21 anchorage semi-dependent cell line in different production systems [ J ] . Turkish Journal of Biochemistry-Turk J Bioehem, 2012, 37 ( 3 ) : 280-286.
  • 9Cruz HJ, Freitas CM, Alves PM, et al. Effects of ammonia and lactate on growth, metabolism, and productivity of BHK cells [ J ] . Enzyme and Microbial Technology, 2000, 27 ( 1-2 ) : 43-52.
  • 10Rourou S, van der Ark A, van der Velden T, et al. Development of an an!real-component free medium for vero cells culture [ J ] . Biotechnol Prog, 2009, 25 ( 6 ) : 1752-1761.

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部